Crossmark

First seroprevalence study of West Nile Virus (WNV) infection in blood donors after the upsurge of West Nile Neuroinvasive Disease (WNND) cases in southern Italy in 2023

Crossref DOI link: https://doi.org/10.1186/s12879-025-10603-4

Published Online: 2025-02-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Centrone, Francesca

Procacci, Rossella

Melilli, Raffaella

Orlando, Valentina Annachiara

Colella, Vito

Loconsole, Daniela

Amendola, Antonello

Venturi, Giulietta

Ostuni, Angelo

Chironna, Maria

,

Serlenga, E.

Abbruzzese, L.

Sticchi Damiani, A.

Lorusso, L.

D’Alagni, M.

Iannone, A. M.

Granato, T.

De Michele, M.
Funding

Funding for this research was provided by:

NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (PE00000007, INF-ACT)
License Information

Text and Data Mining valid from 2025-02-10

Version of Record valid from 2025-02-10
More Information

Article History

Received: 30 October 2024

Accepted: 5 February 2025

First Online: 10 February 2025

Declarations

:

: Ethics approval was obtained from the Ethics Committee of the IRCCS Istituto Oncologico Giovanni Paolo II, Bari, Italy (Prot. N. 594, 24/10/2023 – Studio 1408/CEL – WNV Pug.23). Written informed consent was obtained from the participants. This study was conducted according to the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below